D00539 | |
D number | D00539 |
Classification | Drug |
Name | Ethosuximide (JP17/USP/INN); Zarontin (TN) |
Component | - |
Formula | C7H11NO2 |
Exact mass | 141.079 |
Mol weight | 141.1677 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Neuropsychiatric agent DG02033 Succinimide antiepileptics Other DG01575 Calcium channel blocker DG01573 Calcium channel T type blocker Cyp substrate DG01633 CYP3A substrate |
Remark | Same as: C07505 Therapeutic category: 1139 ATC code: N03AD01 Chemical group: DG02416 |
Activity | - |
Disease | - |
Comment | Succinimide derivative |
Target | CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854] |
Metabolism | Enzyme: CYP3A4 [HSA:1576] |
Interaction | |
Other DBs | CAS: 77-67-8 PubChem: 7847605 ChEBI: 4887 ChEMBL: CHEMBL696 DrugBank: DB00593 LigandBox: D00539 NIKKAJI: J1.477J |
KCF data | - |